Gorbunova, V., & Hofheinz, R. (2019). A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer. British journal of cancer, 120(2), . https://doi.org/10.1038/s41416-018-0343-z
Chicago-Zitierstil (17. Ausg.)Gorbunova, Vera, und Ralf-Dieter Hofheinz. "A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer." British Journal of Cancer 120, no. 2 (2019). https://doi.org/10.1038/s41416-018-0343-z.
MLA-Zitierstil (9. Ausg.)Gorbunova, Vera, und Ralf-Dieter Hofheinz. "A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer." British Journal of Cancer, vol. 120, no. 2, 2019, https://doi.org/10.1038/s41416-018-0343-z.